Ceftazidime-Resistant Klebsiella pneumoniae and Escherichia coli Bloodstream Infection: A Case-Control and Molecular Epidemiologic Investigation

In a molecular, microbiologic, and case-control study to describe the epidemiology of ceftazidime-resistant Klebsiella pneumoniae and Escherichia coli bloodstream infection, 32 unique isolates were recovered over 31 months from the blood of patients hospitalized in a 900-bed hospital in Chicago. Mul...

Full description

Saved in:
Bibliographic Details
Published in:The Journal of infectious diseases Vol. 174; no. 3; pp. 529 - 536
Main Authors: Schiappa, Deborah A., Hayden, Mary K., Matushek, Marian G., Hashemi, Farah N., Sullivan, James, Smith, Kimberly Y., Miyashiro, Deborah, Quinn, John P., Weinstein, Robert A., Trenholme, Gordon M.
Format: Journal Article
Language:English
Published: United States The University of Chicago Press 01-09-1996
University of Chicago Press
Oxford University Press
Subjects:
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:In a molecular, microbiologic, and case-control study to describe the epidemiology of ceftazidime-resistant Klebsiella pneumoniae and Escherichia coli bloodstream infection, 32 unique isolates were recovered over 31 months from the blood of patients hospitalized in a 900-bed hospital in Chicago. Multivariate analysis revealed cases occurred more frequently in debilitated nursing home patients with central venous catheters than in younger, healthier patients. Mortality rates were similar for cases and controls. Case-patients were less likely to die if they received appropriate antibiotic treatment within 3 days of bacteremia onset (P = .02). Pulsed-field gel electrophoresis analysis indicated a polyclonal outbreak, with strain-specific temporal and geographic clustering. Isoelectric focusing results suggested that a predominant enzyme, TEM-10, was responsible for the ceftazidime resistance. The resistance gene was usually carried on a large conjugative plasmid. The polyclonality of the resistant strains suggests that ceftazidime resistance due to TEM-10 is now endemic in Chicago.
Bibliography:Reprints or correspondence: Dr. Gordon M. Trenholme, Section of Infectious Disease, Rush-Presbyterian-St. Luke's Medical Center, 600 S. Paulina, Suite 143 AcFac, Chicago, IL 60612.
istex:4AE28836A65EF3C2EB8FBF0F7F4D4DB1727662FD
ark:/67375/HXZ-LW28C28K-3
ObjectType-Article-2
SourceType-Scholarly Journals-1
ObjectType-Feature-1
content type line 23
ObjectType-Article-1
ObjectType-Feature-2
ISSN:0022-1899
1537-6613
DOI:10.1093/infdis/174.3.529